SAN PEDRO, Calif.--(BUSINESS WIRE)--For the first time, Celprogen researchers have de-differentiated human somatic fibroblasts into cells that eventually become eggs and sperm, possibly opening the door for new treatments for infertility using patient-specific cells.
